0.4979

2.66% 0.0129

After Hours: .51 0.0121 +2.43%

T 2 Biosystems Inc (TTOO)

Overview News Price History Financials Why TTOO Down? Discussions Forecast Stock Split

T 2 Biosystems Inc stock is traded at $0.4979, with a volume of 717.44K. It is up +2.66% in the last 24 hours and down -53.90% over the past month. T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.

Previous Close:

$0.485

Open:

$0.4799

24h Volume:

717.44K

Relative Volume:

1.25

Market Cap:

$10.61M

Revenue:

$7.19M

Net Income/Loss:

$-50.08M

P/E Ratio:

-0.00174

EPS:

-286.9

Net Cash Flow:

$-48.33M

1W Performance:

+7.82%

1M Performance:

-53.90%

6M Performance:

-89.94%

1Y Performance:

-87.03%

1-Day Range:

$0.4799

$0.523

1-Week Range:

$0.4156

$0.5343

52-Week Range:

$0.4156

$8.3799

T 2 Biosystems Inc Stock (TTOO) Company Profile

Name

T 2 Biosystems Inc

Sector

Healthcare (1200)

Industry

Diagnostics & Research (57)

Phone

781-457-1200

Address

101 HARTWELL AVENUE, LEXINGTON

Employee

113

Twitter

@T2Bio

Next Earnings Date

2024-11-04

Latest SEC Filings

TTOO's Discussions on Twitter

Compare TTOO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TTOO T 2 Biosystems Inc	0.4979	10.61M	7.19M	-50.08M	-48.33M	-286.90
TMO Thermo Fisher Scientific Inc	521.66	199.82B	42.37B	6.14B	7.78B	15.26
DHR Danaher Corp	238.83	173.66B	23.74B	3.89B	4.98B	7.93
A Agilent Technologies Inc	138.14	38.64B	6.51B	1.29B	1.37B	3.82
IQV Iqvia Holdings Inc	201.43	36.52B	15.32B	1.41B	1.96B	5.95
IDXX Idexx Laboratories Inc	421.76	34.55B	3.84B	866.24M	792.60M	9.80

T 2 Biosystems Inc Stock (TTOO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-27-21	Downgrade	Alliance Global Partners	Buy → Neutral
Oct-08-20	Initiated	BTIG Research	Buy
Nov-26-19	Downgrade	Janney	Buy → Neutral
Aug-01-19	Downgrade	Alliance Global Partners	Buy → Neutral
Jul-31-19	Downgrade	H.C. Wainwright	Buy → Neutral
Jul-31-19	Downgrade	Janney	Buy → Neutral
May-16-19	Initiated	Alliance Global Partners	Buy
Mar-08-19	Reiterated	H.C. Wainwright	Buy
Jun-01-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
May-30-18	Reiterated	H.C. Wainwright	Buy
May-29-18	Reiterated	WBB Securities	Strong Buy
Mar-29-18	Reiterated	H.C. Wainwright	Buy
Jan-29-18	Initiated	Goldman	Neutral
Oct-18-17	Initiated	H.C. Wainwright	Buy
Mar-15-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Nov-10-16	Resumed	Leerink Partners	Mkt Perform
Nov-02-16	Reiterated	Cantor Fitzgerald	Buy
Jul-20-16	Upgrade	WBB Securities	Buy → Strong Buy
Jun-22-16	Upgrade	WBB Securities	Speculative Buy → Buy
Apr-12-16	Reiterated	Canaccord Genuity	Buy
Feb-17-16	Initiated	WBB Securities	Speculative Buy

View All

T 2 Biosystems Inc Stock (TTOO) Latest News

Nov 27, 2024

StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO) - Defense World

Nov 27, 2024

Nov 22, 2024

T2 Biosystems stock plunges to 52-week low of $0.44 By Investing.com - Investing.com Canada

Nov 22, 2024

Nov 21, 2024

T2 Biosystems stock plunges to 52-week low of $0.44 - Investing.com

Nov 21, 2024

Nov 17, 2024

T2 Biosystems Reports Strong Q3 Financial Results and Operational Updates - Defense World

Nov 17, 2024

Nov 15, 2024

T2 Biosystems, Inc. (NASDAQ:TTOO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

T2 Biosystems: Q3 Earnings Snapshot - mySA

Nov 15, 2024

Earnings call: T2 Biosystems reports growth and strategic partnerships - Investing.com

Nov 15, 2024

Earnings call: T2 Biosystems reports growth and strategic partnerships By Investing.com - Investing.com UK

Nov 15, 2024